nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—BCL2—type 2 diabetes mellitus	0.154	0.411	CbGaD
Docetaxel—EGFR—type 2 diabetes mellitus	0.101	0.269	CbGaD
Docetaxel—ABCC2—type 2 diabetes mellitus	0.0832	0.222	CbGaD
Docetaxel—SLCO1B3—Pioglitazone—type 2 diabetes mellitus	0.0517	0.157	CbGbCtD
Docetaxel—SLCO1B3—Valsartan—type 2 diabetes mellitus	0.0421	0.128	CbGbCtD
Docetaxel—CYP3A4—type 2 diabetes mellitus	0.0368	0.0981	CbGaD
Docetaxel—SLCO1B3—Losartan—type 2 diabetes mellitus	0.0242	0.0735	CbGbCtD
Docetaxel—SLC22A7—Glyburide—type 2 diabetes mellitus	0.0233	0.0708	CbGbCtD
Docetaxel—ABCC1—Glyburide—type 2 diabetes mellitus	0.0183	0.0556	CbGbCtD
Docetaxel—ABCC2—Glyburide—type 2 diabetes mellitus	0.0135	0.0411	CbGbCtD
Docetaxel—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0134	0.0406	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0134	0.0406	CbGbCtD
Docetaxel—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0134	0.0406	CbGbCtD
Docetaxel—ABCG2—Glyburide—type 2 diabetes mellitus	0.0122	0.0372	CbGbCtD
Docetaxel—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0119	0.0362	CbGbCtD
Docetaxel—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.01	0.0305	CbGbCtD
Docetaxel—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00862	0.0262	CbGbCtD
Docetaxel—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00801	0.0243	CbGbCtD
Docetaxel—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00714	0.0217	CbGbCtD
Docetaxel—MAP2—middle cerebral artery—type 2 diabetes mellitus	0.00714	0.148	CbGeAlD
Docetaxel—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00653	0.0198	CbGbCtD
Docetaxel—CYP3A5—Losartan—type 2 diabetes mellitus	0.0062	0.0188	CbGbCtD
Docetaxel—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00592	0.018	CbGbCtD
Docetaxel—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00571	0.0173	CbGbCtD
Docetaxel—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00516	0.0157	CbGbCtD
Docetaxel—ABCB1—Glyburide—type 2 diabetes mellitus	0.00441	0.0134	CbGbCtD
Docetaxel—ABCB1—Losartan—type 2 diabetes mellitus	0.00404	0.0123	CbGbCtD
Docetaxel—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00391	0.0119	CbGbCtD
Docetaxel—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00375	0.0114	CbGbCtD
Docetaxel—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00375	0.0114	CbGbCtD
Docetaxel—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00355	0.0108	CbGbCtD
Docetaxel—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00264	0.00803	CbGbCtD
Docetaxel—CYP3A4—Losartan—type 2 diabetes mellitus	0.00242	0.00735	CbGbCtD
Docetaxel—MAP2—nerve—type 2 diabetes mellitus	0.00152	0.0314	CbGeAlD
Docetaxel—Paclitaxel—BCL2—type 2 diabetes mellitus	0.00111	0.482	CrCbGaD
Docetaxel—MAPT—retina—type 2 diabetes mellitus	0.00101	0.021	CbGeAlD
Docetaxel—MAPT—nephron tubule—type 2 diabetes mellitus	0.000955	0.0198	CbGeAlD
Docetaxel—TUBB6—Irbesartan—Valsartan—type 2 diabetes mellitus	0.000834	0.54	CbGdCrCtD
Docetaxel—MAPT—cortex of kidney—type 2 diabetes mellitus	0.000817	0.0169	CbGeAlD
Docetaxel—MAP4—retina—type 2 diabetes mellitus	0.000797	0.0165	CbGeAlD
Docetaxel—MAPT—adipose tissue—type 2 diabetes mellitus	0.000756	0.0157	CbGeAlD
Docetaxel—MAP2—islet of Langerhans—type 2 diabetes mellitus	0.000734	0.0152	CbGeAlD
Docetaxel—TUBB6—Irbesartan—Losartan—type 2 diabetes mellitus	0.00071	0.46	CbGdCrCtD
Docetaxel—MAP4—cardiovascular system—type 2 diabetes mellitus	0.000674	0.014	CbGeAlD
Docetaxel—MAP4—kidney—type 2 diabetes mellitus	0.00066	0.0137	CbGeAlD
Docetaxel—MAP4—pancreas—type 2 diabetes mellitus	0.000655	0.0136	CbGeAlD
Docetaxel—MAP4—cortex of kidney—type 2 diabetes mellitus	0.000642	0.0133	CbGeAlD
Docetaxel—NR1I2—liver—type 2 diabetes mellitus	0.000637	0.0132	CbGeAlD
Docetaxel—MAP2—retina—type 2 diabetes mellitus	0.000628	0.013	CbGeAlD
Docetaxel—BCL2—cardiovascular system—type 2 diabetes mellitus	0.000613	0.0127	CbGeAlD
Docetaxel—BCL2—kidney—type 2 diabetes mellitus	0.0006	0.0124	CbGeAlD
Docetaxel—Paclitaxel—ABCC2—type 2 diabetes mellitus	0.0006	0.26	CrCbGaD
Docetaxel—MAP4—adipose tissue—type 2 diabetes mellitus	0.000594	0.0123	CbGeAlD
Docetaxel—TUBB1—adipose tissue—type 2 diabetes mellitus	0.000581	0.0121	CbGeAlD
Docetaxel—TUBB2B—islet of Langerhans—type 2 diabetes mellitus	0.000548	0.0114	CbGeAlD
Docetaxel—EGFR—adipose tissue—type 2 diabetes mellitus	0.000534	0.0111	CbGeAlD
Docetaxel—MAP2—cardiovascular system—type 2 diabetes mellitus	0.000531	0.011	CbGeAlD
Docetaxel—TUBB—islet of Langerhans—type 2 diabetes mellitus	0.000519	0.0108	CbGeAlD
Docetaxel—TUBB2A—islet of Langerhans—type 2 diabetes mellitus	0.000516	0.0107	CbGeAlD
Docetaxel—MAP2—pancreas—type 2 diabetes mellitus	0.000516	0.0107	CbGeAlD
Docetaxel—TUBB6—islet of Langerhans—type 2 diabetes mellitus	0.000509	0.0106	CbGeAlD
Docetaxel—MAP2—cortex of kidney—type 2 diabetes mellitus	0.000506	0.0105	CbGeAlD
Docetaxel—TUBB4A—retina—type 2 diabetes mellitus	0.000485	0.0101	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000471	0.00978	CbGeAlD
Docetaxel—TUBB2B—retina—type 2 diabetes mellitus	0.000469	0.00972	CbGeAlD
Docetaxel—MAP2—adipose tissue—type 2 diabetes mellitus	0.000468	0.00971	CbGeAlD
Docetaxel—SLC22A7—kidney—type 2 diabetes mellitus	0.000449	0.00931	CbGeAlD
Docetaxel—TUBB4B—islet of Langerhans—type 2 diabetes mellitus	0.000442	0.00918	CbGeAlD
Docetaxel—TUBB2B—nephron tubule—type 2 diabetes mellitus	0.000441	0.00916	CbGeAlD
Docetaxel—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.000437	0.00907	CbGeAlD
Docetaxel—TUBB—nephron tubule—type 2 diabetes mellitus	0.000418	0.00867	CbGeAlD
Docetaxel—MAP4—liver—type 2 diabetes mellitus	0.000417	0.00865	CbGeAlD
Docetaxel—TUBB2A—nephron tubule—type 2 diabetes mellitus	0.000416	0.00862	CbGeAlD
Docetaxel—TUBB4A—cardiovascular system—type 2 diabetes mellitus	0.00041	0.00851	CbGeAlD
Docetaxel—TUBB6—nephron tubule—type 2 diabetes mellitus	0.00041	0.0085	CbGeAlD
Docetaxel—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000403	0.00837	CbGeAlD
Docetaxel—TUBB4A—kidney—type 2 diabetes mellitus	0.000401	0.00833	CbGeAlD
Docetaxel—TUBB4A—pancreas—type 2 diabetes mellitus	0.000399	0.00827	CbGeAlD
Docetaxel—TUBB2B—pancreas—type 2 diabetes mellitus	0.000385	0.00799	CbGeAlD
Docetaxel—TUBB4B—retina—type 2 diabetes mellitus	0.000378	0.00785	CbGeAlD
Docetaxel—TUBB2B—cortex of kidney—type 2 diabetes mellitus	0.000378	0.00784	CbGeAlD
Docetaxel—EGFR—liver—type 2 diabetes mellitus	0.000374	0.00777	CbGeAlD
Docetaxel—TUBB6—cardiovascular system—type 2 diabetes mellitus	0.000368	0.00764	CbGeAlD
Docetaxel—SLCO1B3—liver—type 2 diabetes mellitus	0.000365	0.00757	CbGeAlD
Docetaxel—TUBB—pancreas—type 2 diabetes mellitus	0.000365	0.00757	CbGeAlD
Docetaxel—TUBB2A—pancreas—type 2 diabetes mellitus	0.000363	0.00753	CbGeAlD
Docetaxel—TUBB6—kidney—type 2 diabetes mellitus	0.00036	0.00747	CbGeAlD
Docetaxel—TUBB6—pancreas—type 2 diabetes mellitus	0.000358	0.00742	CbGeAlD
Docetaxel—TUBB—cortex of kidney—type 2 diabetes mellitus	0.000358	0.00742	CbGeAlD
Docetaxel—TUBB4B—nephron tubule—type 2 diabetes mellitus	0.000356	0.00739	CbGeAlD
Docetaxel—TUBB2A—cortex of kidney—type 2 diabetes mellitus	0.000356	0.00738	CbGeAlD
Docetaxel—TUBB6—cortex of kidney—type 2 diabetes mellitus	0.000351	0.00728	CbGeAlD
Docetaxel—TUBB2B—adipose tissue—type 2 diabetes mellitus	0.00035	0.00725	CbGeAlD
Docetaxel—TUBB—adipose tissue—type 2 diabetes mellitus	0.000331	0.00686	CbGeAlD
Docetaxel—TUBB2A—adipose tissue—type 2 diabetes mellitus	0.000329	0.00683	CbGeAlD
Docetaxel—MAP2—liver—type 2 diabetes mellitus	0.000328	0.00681	CbGeAlD
Docetaxel—Cabazitaxel—CYP3A4—type 2 diabetes mellitus	0.000328	0.143	CrCbGaD
Docetaxel—TUBB6—adipose tissue—type 2 diabetes mellitus	0.000325	0.00673	CbGeAlD
Docetaxel—TUBB4B—cardiovascular system—type 2 diabetes mellitus	0.00032	0.00664	CbGeAlD
Docetaxel—ABCC10—kidney—type 2 diabetes mellitus	0.000315	0.00654	CbGeAlD
Docetaxel—TUBB4B—kidney—type 2 diabetes mellitus	0.000313	0.00649	CbGeAlD
Docetaxel—TUBB4B—pancreas—type 2 diabetes mellitus	0.000311	0.00645	CbGeAlD
Docetaxel—CYP3A7—liver—type 2 diabetes mellitus	0.000308	0.00639	CbGeAlD
Docetaxel—ABCC10—cortex of kidney—type 2 diabetes mellitus	0.000307	0.00637	CbGeAlD
Docetaxel—TUBB4B—cortex of kidney—type 2 diabetes mellitus	0.000305	0.00633	CbGeAlD
Docetaxel—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000288	0.00598	CbGeAlD
Docetaxel—ABCC10—adipose tissue—type 2 diabetes mellitus	0.000284	0.0059	CbGeAlD
Docetaxel—SLC22A7—liver—type 2 diabetes mellitus	0.000284	0.00589	CbGeAlD
Docetaxel—CYP1B1—nephron tubule—type 2 diabetes mellitus	0.000282	0.00585	CbGeAlD
Docetaxel—TUBB4B—adipose tissue—type 2 diabetes mellitus	0.000282	0.00585	CbGeAlD
Docetaxel—Paclitaxel—CYP3A4—type 2 diabetes mellitus	0.000265	0.115	CrCbGaD
Docetaxel—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000262	0.00543	CbGeAlD
Docetaxel—TUBB4A—liver—type 2 diabetes mellitus	0.000254	0.00526	CbGeAlD
Docetaxel—CYP1B1—cardiovascular system—type 2 diabetes mellitus	0.000253	0.00526	CbGeAlD
Docetaxel—ABCC2—kidney—type 2 diabetes mellitus	0.000253	0.00525	CbGeAlD
Docetaxel—CYP1B1—kidney—type 2 diabetes mellitus	0.000248	0.00514	CbGeAlD
Docetaxel—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000247	0.00512	CbGeAlD
Docetaxel—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000242	0.00503	CbGeAlD
Docetaxel—CYP1B1—cortex of kidney—type 2 diabetes mellitus	0.000242	0.00501	CbGeAlD
Docetaxel—TUBB—liver—type 2 diabetes mellitus	0.000232	0.00481	CbGeAlD
Docetaxel—TUBB2A—liver—type 2 diabetes mellitus	0.000231	0.00479	CbGeAlD
Docetaxel—TUBB6—liver—type 2 diabetes mellitus	0.000228	0.00472	CbGeAlD
Docetaxel—CYP1B1—adipose tissue—type 2 diabetes mellitus	0.000224	0.00464	CbGeAlD
Docetaxel—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.000217	0.00451	CbGeAlD
Docetaxel—ABCG2—nephron tubule—type 2 diabetes mellitus	0.00021	0.00436	CbGeAlD
Docetaxel—ABCC1—adipose tissue—type 2 diabetes mellitus	0.000201	0.00417	CbGeAlD
Docetaxel—ABCC10—liver—type 2 diabetes mellitus	0.000199	0.00413	CbGeAlD
Docetaxel—TUBB4B—liver—type 2 diabetes mellitus	0.000198	0.00411	CbGeAlD
Docetaxel—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000195	0.00405	CbGeAlD
Docetaxel—CYP3A5—kidney—type 2 diabetes mellitus	0.000171	0.00356	CbGeAlD
Docetaxel—CYP3A5—pancreas—type 2 diabetes mellitus	0.00017	0.00353	CbGeAlD
Docetaxel—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000167	0.00346	CbGeAlD
Docetaxel—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000166	0.00345	CbGeAlD
Docetaxel—ABCC2—liver—type 2 diabetes mellitus	0.00016	0.00332	CbGeAlD
Docetaxel—CYP1B1—liver—type 2 diabetes mellitus	0.000157	0.00325	CbGeAlD
Docetaxel—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000154	0.0032	CbGeAlD
Docetaxel—ABCC1—liver—type 2 diabetes mellitus	0.000141	0.00292	CbGeAlD
Docetaxel—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000129	0.00267	CbGeAlD
Docetaxel—CYP3A4—kidney—type 2 diabetes mellitus	0.000129	0.00267	CbGeAlD
Docetaxel—ABCG2—liver—type 2 diabetes mellitus	0.000117	0.00242	CbGeAlD
Docetaxel—ABCB1—retina—type 2 diabetes mellitus	0.00011	0.00228	CbGeAlD
Docetaxel—CYP3A5—liver—type 2 diabetes mellitus	0.000108	0.00225	CbGeAlD
Docetaxel—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000104	0.00215	CbGeAlD
Docetaxel—ABCB1—cardiovascular system—type 2 diabetes mellitus	9.31e-05	0.00193	CbGeAlD
Docetaxel—ABCB1—kidney—type 2 diabetes mellitus	9.11e-05	0.00189	CbGeAlD
Docetaxel—ABCB1—pancreas—type 2 diabetes mellitus	9.05e-05	0.00188	CbGeAlD
Docetaxel—ABCB1—cortex of kidney—type 2 diabetes mellitus	8.87e-05	0.00184	CbGeAlD
Docetaxel—ABCB1—adipose tissue—type 2 diabetes mellitus	8.21e-05	0.0017	CbGeAlD
Docetaxel—CYP3A4—liver—type 2 diabetes mellitus	8.13e-05	0.00169	CbGeAlD
Docetaxel—ABCB1—liver—type 2 diabetes mellitus	5.76e-05	0.00119	CbGeAlD
Docetaxel—Rash—Sitagliptin—type 2 diabetes mellitus	5.53e-05	0.000395	CcSEcCtD
Docetaxel—Dermatitis—Sitagliptin—type 2 diabetes mellitus	5.52e-05	0.000394	CcSEcCtD
Docetaxel—Erythema multiforme—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000394	CcSEcCtD
Docetaxel—Headache—Glimepiride—type 2 diabetes mellitus	5.51e-05	0.000393	CcSEcCtD
Docetaxel—Cough—Irbesartan—type 2 diabetes mellitus	5.5e-05	0.000393	CcSEcCtD
Docetaxel—Headache—Sitagliptin—type 2 diabetes mellitus	5.49e-05	0.000392	CcSEcCtD
Docetaxel—Anaemia—Losartan—type 2 diabetes mellitus	5.48e-05	0.000391	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	5.45e-05	0.000389	CcSEcCtD
Docetaxel—Oedema—Metformin—type 2 diabetes mellitus	5.45e-05	0.000389	CcSEcCtD
Docetaxel—Hypertension—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.000388	CcSEcCtD
Docetaxel—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	5.43e-05	0.000388	CcSEcCtD
Docetaxel—Flushing—Ramipril—type 2 diabetes mellitus	5.42e-05	0.000387	CcSEcCtD
Docetaxel—Infection—Metformin—type 2 diabetes mellitus	5.41e-05	0.000387	CcSEcCtD
Docetaxel—Insomnia—Valsartan—type 2 diabetes mellitus	5.41e-05	0.000386	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	5.39e-05	0.000385	CcSEcCtD
Docetaxel—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.37e-05	0.000384	CcSEcCtD
Docetaxel—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.37e-05	0.000383	CcSEcCtD
Docetaxel—Chest pain—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000383	CcSEcCtD
Docetaxel—Arthralgia—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000383	CcSEcCtD
Docetaxel—Myalgia—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000383	CcSEcCtD
Docetaxel—Shock—Metformin—type 2 diabetes mellitus	5.36e-05	0.000383	CcSEcCtD
Docetaxel—Insomnia—Orlistat—type 2 diabetes mellitus	5.35e-05	0.000382	CcSEcCtD
Docetaxel—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.34e-05	0.000382	CcSEcCtD
Docetaxel—Nervous system disorder—Metformin—type 2 diabetes mellitus	5.34e-05	0.000382	CcSEcCtD
Docetaxel—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.33e-05	0.000381	CcSEcCtD
Docetaxel—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.33e-05	0.000381	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.33e-05	0.00038	CcSEcCtD
Docetaxel—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.33e-05	0.00038	CcSEcCtD
Docetaxel—Somnolence—Valsartan—type 2 diabetes mellitus	5.32e-05	0.00038	CcSEcCtD
Docetaxel—Syncope—Losartan—type 2 diabetes mellitus	5.32e-05	0.00038	CcSEcCtD
Docetaxel—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.31e-05	0.000379	CcSEcCtD
Docetaxel—Leukopenia—Losartan—type 2 diabetes mellitus	5.31e-05	0.000379	CcSEcCtD
Docetaxel—Skin disorder—Metformin—type 2 diabetes mellitus	5.29e-05	0.000378	CcSEcCtD
Docetaxel—Immune system disorder—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000377	CcSEcCtD
Docetaxel—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.27e-05	0.000376	CcSEcCtD
Docetaxel—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.26e-05	0.000376	CcSEcCtD
Docetaxel—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.25e-05	0.000375	CcSEcCtD
Docetaxel—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.25e-05	0.000375	CcSEcCtD
Docetaxel—Palpitations—Losartan—type 2 diabetes mellitus	5.24e-05	0.000374	CcSEcCtD
Docetaxel—Nausea—Glimepiride—type 2 diabetes mellitus	5.22e-05	0.000373	CcSEcCtD
Docetaxel—Arrhythmia—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000373	CcSEcCtD
Docetaxel—Loss of consciousness—Losartan—type 2 diabetes mellitus	5.21e-05	0.000372	CcSEcCtD
Docetaxel—Nausea—Sitagliptin—type 2 diabetes mellitus	5.21e-05	0.000372	CcSEcCtD
Docetaxel—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.2e-05	0.000372	CcSEcCtD
Docetaxel—Asthenia—Glyburide—type 2 diabetes mellitus	5.2e-05	0.000372	CcSEcCtD
Docetaxel—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.2e-05	0.000371	CcSEcCtD
Docetaxel—Anorexia—Metformin—type 2 diabetes mellitus	5.19e-05	0.000371	CcSEcCtD
Docetaxel—Cough—Losartan—type 2 diabetes mellitus	5.17e-05	0.00037	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.17e-05	0.000369	CcSEcCtD
Docetaxel—Alopecia—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000369	CcSEcCtD
Docetaxel—Fatigue—Valsartan—type 2 diabetes mellitus	5.16e-05	0.000368	CcSEcCtD
Docetaxel—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.15e-05	0.000368	CcSEcCtD
Docetaxel—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.15e-05	0.000368	CcSEcCtD
Docetaxel—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000367	CcSEcCtD
Docetaxel—Oedema—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000367	CcSEcCtD
Docetaxel—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.14e-05	0.000367	CcSEcCtD
Docetaxel—Pruritus—Glyburide—type 2 diabetes mellitus	5.13e-05	0.000366	CcSEcCtD
Docetaxel—Mental disorder—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000365	CcSEcCtD
Docetaxel—Constipation—Valsartan—type 2 diabetes mellitus	5.12e-05	0.000365	CcSEcCtD
Docetaxel—Infection—Irbesartan—type 2 diabetes mellitus	5.11e-05	0.000365	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.1e-05	0.000365	CcSEcCtD
Docetaxel—Fatigue—Orlistat—type 2 diabetes mellitus	5.1e-05	0.000364	CcSEcCtD
Docetaxel—Hypotension—Metformin—type 2 diabetes mellitus	5.09e-05	0.000364	CcSEcCtD
Docetaxel—Erythema—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000363	CcSEcCtD
Docetaxel—Malnutrition—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000363	CcSEcCtD
Docetaxel—Shock—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.000361	CcSEcCtD
Docetaxel—Pain—Orlistat—type 2 diabetes mellitus	5.06e-05	0.000361	CcSEcCtD
Docetaxel—Arthralgia—Losartan—type 2 diabetes mellitus	5.05e-05	0.000361	CcSEcCtD
Docetaxel—Myalgia—Losartan—type 2 diabetes mellitus	5.05e-05	0.000361	CcSEcCtD
Docetaxel—Chest pain—Losartan—type 2 diabetes mellitus	5.05e-05	0.000361	CcSEcCtD
Docetaxel—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.04e-05	0.00036	CcSEcCtD
Docetaxel—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.00036	CcSEcCtD
Docetaxel—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.03e-05	0.00036	CcSEcCtD
Docetaxel—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.000358	CcSEcCtD
Docetaxel—Rash—Bromocriptine—type 2 diabetes mellitus	5e-05	0.000357	CcSEcCtD
Docetaxel—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5e-05	0.000357	CcSEcCtD
Docetaxel—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.99e-05	0.000357	CcSEcCtD
Docetaxel—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000356	CcSEcCtD
Docetaxel—Headache—Bromocriptine—type 2 diabetes mellitus	4.97e-05	0.000355	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.96e-05	0.000355	CcSEcCtD
Docetaxel—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.96e-05	0.000354	CcSEcCtD
Docetaxel—Dry mouth—Losartan—type 2 diabetes mellitus	4.94e-05	0.000353	CcSEcCtD
Docetaxel—Anorexia—Irbesartan—type 2 diabetes mellitus	4.9e-05	0.00035	CcSEcCtD
Docetaxel—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.89e-05	0.000349	CcSEcCtD
Docetaxel—Paraesthesia—Metformin—type 2 diabetes mellitus	4.89e-05	0.000349	CcSEcCtD
Docetaxel—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000349	CcSEcCtD
Docetaxel—Confusional state—Losartan—type 2 diabetes mellitus	4.88e-05	0.000348	CcSEcCtD
Docetaxel—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.87e-05	0.000348	CcSEcCtD
Docetaxel—Dyspnoea—Metformin—type 2 diabetes mellitus	4.86e-05	0.000347	CcSEcCtD
Docetaxel—Somnolence—Metformin—type 2 diabetes mellitus	4.84e-05	0.000346	CcSEcCtD
Docetaxel—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.84e-05	0.000346	CcSEcCtD
Docetaxel—Oedema—Losartan—type 2 diabetes mellitus	4.84e-05	0.000346	CcSEcCtD
Docetaxel—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.83e-05	0.000345	CcSEcCtD
Docetaxel—Infection—Losartan—type 2 diabetes mellitus	4.81e-05	0.000343	CcSEcCtD
Docetaxel—Hypotension—Irbesartan—type 2 diabetes mellitus	4.8e-05	0.000343	CcSEcCtD
Docetaxel—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.8e-05	0.000343	CcSEcCtD
Docetaxel—Dyspepsia—Metformin—type 2 diabetes mellitus	4.8e-05	0.000343	CcSEcCtD
Docetaxel—Shock—Losartan—type 2 diabetes mellitus	4.76e-05	0.00034	CcSEcCtD
Docetaxel—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.75e-05	0.000339	CcSEcCtD
Docetaxel—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.74e-05	0.000338	CcSEcCtD
Docetaxel—Decreased appetite—Metformin—type 2 diabetes mellitus	4.74e-05	0.000338	CcSEcCtD
Docetaxel—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.73e-05	0.000338	CcSEcCtD
Docetaxel—Tachycardia—Losartan—type 2 diabetes mellitus	4.72e-05	0.000337	CcSEcCtD
Docetaxel—Nausea—Bromocriptine—type 2 diabetes mellitus	4.71e-05	0.000337	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.7e-05	0.000336	CcSEcCtD
Docetaxel—Fatigue—Metformin—type 2 diabetes mellitus	4.7e-05	0.000335	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000335	CcSEcCtD
Docetaxel—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.67e-05	0.000334	CcSEcCtD
Docetaxel—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.67e-05	0.000334	CcSEcCtD
Docetaxel—Asthenia—Gliclazide—type 2 diabetes mellitus	4.67e-05	0.000334	CcSEcCtD
Docetaxel—Constipation—Metformin—type 2 diabetes mellitus	4.66e-05	0.000333	CcSEcCtD
Docetaxel—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.62e-05	0.00033	CcSEcCtD
Docetaxel—Anorexia—Losartan—type 2 diabetes mellitus	4.61e-05	0.000329	CcSEcCtD
Docetaxel—Vomiting—Glyburide—type 2 diabetes mellitus	4.61e-05	0.000329	CcSEcCtD
Docetaxel—Pruritus—Gliclazide—type 2 diabetes mellitus	4.61e-05	0.000329	CcSEcCtD
Docetaxel—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.58e-05	0.000327	CcSEcCtD
Docetaxel—Rash—Glyburide—type 2 diabetes mellitus	4.57e-05	0.000327	CcSEcCtD
Docetaxel—Somnolence—Irbesartan—type 2 diabetes mellitus	4.57e-05	0.000326	CcSEcCtD
Docetaxel—Dermatitis—Glyburide—type 2 diabetes mellitus	4.57e-05	0.000326	CcSEcCtD
Docetaxel—Syncope—Ramipril—type 2 diabetes mellitus	4.56e-05	0.000326	CcSEcCtD
Docetaxel—Leukopenia—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000325	CcSEcCtD
Docetaxel—Headache—Glyburide—type 2 diabetes mellitus	4.54e-05	0.000324	CcSEcCtD
Docetaxel—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000323	CcSEcCtD
Docetaxel—Hypotension—Losartan—type 2 diabetes mellitus	4.52e-05	0.000323	CcSEcCtD
Docetaxel—Palpitations—Ramipril—type 2 diabetes mellitus	4.49e-05	0.000321	CcSEcCtD
Docetaxel—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.49e-05	0.000321	CcSEcCtD
Docetaxel—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.47e-05	0.000319	CcSEcCtD
Docetaxel—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000319	CcSEcCtD
Docetaxel—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.46e-05	0.000318	CcSEcCtD
Docetaxel—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.46e-05	0.000318	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.44e-05	0.000317	CcSEcCtD
Docetaxel—Cough—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000317	CcSEcCtD
Docetaxel—Fatigue—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000317	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.41e-05	0.000315	CcSEcCtD
Docetaxel—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.41e-05	0.000315	CcSEcCtD
Docetaxel—Convulsion—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000315	CcSEcCtD
Docetaxel—Constipation—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000314	CcSEcCtD
Docetaxel—Pain—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000314	CcSEcCtD
Docetaxel—Insomnia—Losartan—type 2 diabetes mellitus	4.38e-05	0.000313	CcSEcCtD
Docetaxel—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.36e-05	0.000311	CcSEcCtD
Docetaxel—Paraesthesia—Losartan—type 2 diabetes mellitus	4.35e-05	0.00031	CcSEcCtD
Docetaxel—Arthralgia—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000309	CcSEcCtD
Docetaxel—Myalgia—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000309	CcSEcCtD
Docetaxel—Chest pain—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000309	CcSEcCtD
Docetaxel—Dyspnoea—Losartan—type 2 diabetes mellitus	4.31e-05	0.000308	CcSEcCtD
Docetaxel—Nausea—Glyburide—type 2 diabetes mellitus	4.31e-05	0.000308	CcSEcCtD
Docetaxel—Abdominal pain—Metformin—type 2 diabetes mellitus	4.31e-05	0.000308	CcSEcCtD
Docetaxel—Dizziness—Gliclazide—type 2 diabetes mellitus	4.31e-05	0.000308	CcSEcCtD
Docetaxel—Somnolence—Losartan—type 2 diabetes mellitus	4.3e-05	0.000307	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000307	CcSEcCtD
Docetaxel—Asthenia—Valsartan—type 2 diabetes mellitus	4.29e-05	0.000307	CcSEcCtD
Docetaxel—Dyspepsia—Losartan—type 2 diabetes mellitus	4.26e-05	0.000304	CcSEcCtD
Docetaxel—Asthenia—Orlistat—type 2 diabetes mellitus	4.24e-05	0.000303	CcSEcCtD
Docetaxel—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.000303	CcSEcCtD
Docetaxel—Pruritus—Valsartan—type 2 diabetes mellitus	4.23e-05	0.000302	CcSEcCtD
Docetaxel—Dry mouth—Ramipril—type 2 diabetes mellitus	4.23e-05	0.000302	CcSEcCtD
Docetaxel—Decreased appetite—Losartan—type 2 diabetes mellitus	4.21e-05	0.0003	CcSEcCtD
Docetaxel—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.2e-05	0.0003	CcSEcCtD
Docetaxel—Confusional state—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000299	CcSEcCtD
Docetaxel—Pruritus—Orlistat—type 2 diabetes mellitus	4.18e-05	0.000299	CcSEcCtD
Docetaxel—Fatigue—Losartan—type 2 diabetes mellitus	4.17e-05	0.000298	CcSEcCtD
Docetaxel—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000296	CcSEcCtD
Docetaxel—Oedema—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000296	CcSEcCtD
Docetaxel—Vomiting—Gliclazide—type 2 diabetes mellitus	4.14e-05	0.000296	CcSEcCtD
Docetaxel—Pain—Losartan—type 2 diabetes mellitus	4.14e-05	0.000296	CcSEcCtD
Docetaxel—Constipation—Losartan—type 2 diabetes mellitus	4.14e-05	0.000296	CcSEcCtD
Docetaxel—Rash—Gliclazide—type 2 diabetes mellitus	4.11e-05	0.000293	CcSEcCtD
Docetaxel—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.1e-05	0.000293	CcSEcCtD
Docetaxel—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.09e-05	0.000292	CcSEcCtD
Docetaxel—Shock—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000292	CcSEcCtD
Docetaxel—Headache—Gliclazide—type 2 diabetes mellitus	4.08e-05	0.000291	CcSEcCtD
Docetaxel—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000291	CcSEcCtD
Docetaxel—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.00029	CcSEcCtD
Docetaxel—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.06e-05	0.00029	CcSEcCtD
Docetaxel—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.06e-05	0.00029	CcSEcCtD
Docetaxel—Tachycardia—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000289	CcSEcCtD
Docetaxel—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.05e-05	0.000289	CcSEcCtD
Docetaxel—Skin disorder—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000288	CcSEcCtD
Docetaxel—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.99e-05	0.000285	CcSEcCtD
Docetaxel—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.96e-05	0.000283	CcSEcCtD
Docetaxel—Dizziness—Valsartan—type 2 diabetes mellitus	3.96e-05	0.000283	CcSEcCtD
Docetaxel—Anorexia—Ramipril—type 2 diabetes mellitus	3.96e-05	0.000282	CcSEcCtD
Docetaxel—Dizziness—Orlistat—type 2 diabetes mellitus	3.91e-05	0.000279	CcSEcCtD
Docetaxel—Asthenia—Metformin—type 2 diabetes mellitus	3.91e-05	0.000279	CcSEcCtD
Docetaxel—Hypotension—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000277	CcSEcCtD
Docetaxel—Nausea—Gliclazide—type 2 diabetes mellitus	3.87e-05	0.000276	CcSEcCtD
Docetaxel—Pruritus—Metformin—type 2 diabetes mellitus	3.85e-05	0.000275	CcSEcCtD
Docetaxel—Body temperature increased—Losartan—type 2 diabetes mellitus	3.83e-05	0.000273	CcSEcCtD
Docetaxel—Abdominal pain—Losartan—type 2 diabetes mellitus	3.83e-05	0.000273	CcSEcCtD
Docetaxel—Vomiting—Valsartan—type 2 diabetes mellitus	3.8e-05	0.000272	CcSEcCtD
Docetaxel—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.79e-05	0.000271	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.78e-05	0.00027	CcSEcCtD
Docetaxel—Rash—Valsartan—type 2 diabetes mellitus	3.77e-05	0.000269	CcSEcCtD
Docetaxel—Dermatitis—Valsartan—type 2 diabetes mellitus	3.77e-05	0.000269	CcSEcCtD
Docetaxel—Vomiting—Orlistat—type 2 diabetes mellitus	3.76e-05	0.000268	CcSEcCtD
Docetaxel—Insomnia—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000268	CcSEcCtD
Docetaxel—Headache—Valsartan—type 2 diabetes mellitus	3.75e-05	0.000268	CcSEcCtD
Docetaxel—Diarrhoea—Metformin—type 2 diabetes mellitus	3.73e-05	0.000266	CcSEcCtD
Docetaxel—Rash—Orlistat—type 2 diabetes mellitus	3.73e-05	0.000266	CcSEcCtD
Docetaxel—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000266	CcSEcCtD
Docetaxel—Dermatitis—Orlistat—type 2 diabetes mellitus	3.72e-05	0.000266	CcSEcCtD
Docetaxel—Headache—Orlistat—type 2 diabetes mellitus	3.7e-05	0.000265	CcSEcCtD
Docetaxel—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000264	CcSEcCtD
Docetaxel—Asthenia—Irbesartan—type 2 diabetes mellitus	3.69e-05	0.000263	CcSEcCtD
Docetaxel—Somnolence—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000263	CcSEcCtD
Docetaxel—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000261	CcSEcCtD
Docetaxel—Pruritus—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.00026	CcSEcCtD
Docetaxel—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.61e-05	0.000258	CcSEcCtD
Docetaxel—Dizziness—Metformin—type 2 diabetes mellitus	3.6e-05	0.000257	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000256	CcSEcCtD
Docetaxel—Fatigue—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000255	CcSEcCtD
Docetaxel—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.57e-05	0.000255	CcSEcCtD
Docetaxel—Nausea—Valsartan—type 2 diabetes mellitus	3.55e-05	0.000254	CcSEcCtD
Docetaxel—Constipation—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000253	CcSEcCtD
Docetaxel—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.52e-05	0.000251	CcSEcCtD
Docetaxel—Nausea—Orlistat—type 2 diabetes mellitus	3.51e-05	0.000251	CcSEcCtD
Docetaxel—Asthenia—Losartan—type 2 diabetes mellitus	3.47e-05	0.000248	CcSEcCtD
Docetaxel—Vomiting—Metformin—type 2 diabetes mellitus	3.46e-05	0.000247	CcSEcCtD
Docetaxel—Rash—Metformin—type 2 diabetes mellitus	3.44e-05	0.000245	CcSEcCtD
Docetaxel—Dermatitis—Metformin—type 2 diabetes mellitus	3.43e-05	0.000245	CcSEcCtD
Docetaxel—Pruritus—Losartan—type 2 diabetes mellitus	3.42e-05	0.000245	CcSEcCtD
Docetaxel—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000244	CcSEcCtD
Docetaxel—Headache—Metformin—type 2 diabetes mellitus	3.41e-05	0.000244	CcSEcCtD
Docetaxel—Dizziness—Irbesartan—type 2 diabetes mellitus	3.4e-05	0.000243	CcSEcCtD
Docetaxel—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000242	CcSEcCtD
Docetaxel—Diarrhoea—Losartan—type 2 diabetes mellitus	3.31e-05	0.000236	CcSEcCtD
Docetaxel—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000234	CcSEcCtD
Docetaxel—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.28e-05	0.000234	CcSEcCtD
Docetaxel—Vomiting—Irbesartan—type 2 diabetes mellitus	3.27e-05	0.000233	CcSEcCtD
Docetaxel—Rash—Irbesartan—type 2 diabetes mellitus	3.24e-05	0.000232	CcSEcCtD
Docetaxel—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.24e-05	0.000231	CcSEcCtD
Docetaxel—Nausea—Metformin—type 2 diabetes mellitus	3.24e-05	0.000231	CcSEcCtD
Docetaxel—Headache—Irbesartan—type 2 diabetes mellitus	3.22e-05	0.00023	CcSEcCtD
Docetaxel—Dizziness—Losartan—type 2 diabetes mellitus	3.2e-05	0.000229	CcSEcCtD
Docetaxel—Vomiting—Losartan—type 2 diabetes mellitus	3.08e-05	0.00022	CcSEcCtD
Docetaxel—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000218	CcSEcCtD
Docetaxel—Nausea—Irbesartan—type 2 diabetes mellitus	3.05e-05	0.000218	CcSEcCtD
Docetaxel—Rash—Losartan—type 2 diabetes mellitus	3.05e-05	0.000218	CcSEcCtD
Docetaxel—Dermatitis—Losartan—type 2 diabetes mellitus	3.05e-05	0.000218	CcSEcCtD
Docetaxel—Headache—Losartan—type 2 diabetes mellitus	3.03e-05	0.000217	CcSEcCtD
Docetaxel—Asthenia—Ramipril—type 2 diabetes mellitus	2.98e-05	0.000213	CcSEcCtD
Docetaxel—Pruritus—Ramipril—type 2 diabetes mellitus	2.94e-05	0.00021	CcSEcCtD
Docetaxel—Nausea—Losartan—type 2 diabetes mellitus	2.87e-05	0.000205	CcSEcCtD
Docetaxel—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.84e-05	0.000203	CcSEcCtD
Docetaxel—Dizziness—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000196	CcSEcCtD
Docetaxel—Vomiting—Ramipril—type 2 diabetes mellitus	2.64e-05	0.000188	CcSEcCtD
Docetaxel—Rash—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000187	CcSEcCtD
Docetaxel—Dermatitis—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000187	CcSEcCtD
Docetaxel—Headache—Ramipril—type 2 diabetes mellitus	2.6e-05	0.000186	CcSEcCtD
Docetaxel—Nausea—Ramipril—type 2 diabetes mellitus	2.46e-05	0.000176	CcSEcCtD
Docetaxel—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	2.17e-06	2.08e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.17e-06	2.08e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CALM1—type 2 diabetes mellitus	2.16e-06	2.07e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—type 2 diabetes mellitus	2.16e-06	2.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.16e-06	2.07e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—APOE—type 2 diabetes mellitus	2.16e-06	2.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—INS—type 2 diabetes mellitus	2.14e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	2.14e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	2.14e-06	2.05e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—APOA1—type 2 diabetes mellitus	2.13e-06	2.04e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	2.13e-06	2.04e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	2.13e-06	2.04e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	2.12e-06	2.03e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	2.12e-06	2.03e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	2.12e-06	2.03e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	2.11e-06	2.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—LPL—type 2 diabetes mellitus	2.1e-06	2.01e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	2.09e-06	2e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	2.09e-06	2e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	2.09e-06	2e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	2.07e-06	1.99e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	2.07e-06	1.99e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	2.07e-06	1.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT2—type 2 diabetes mellitus	2.07e-06	1.99e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	2.07e-06	1.98e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.06e-06	1.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.05e-06	1.97e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	2.05e-06	1.96e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PIK3R1—type 2 diabetes mellitus	2.03e-06	1.95e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	2.03e-06	1.95e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	2.03e-06	1.95e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.02e-06	1.94e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	2e-06	1.92e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	2e-06	1.92e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	1.99e-06	1.91e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NOS3—type 2 diabetes mellitus	1.99e-06	1.91e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	1.98e-06	1.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—type 2 diabetes mellitus	1.97e-06	1.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SERPINE1—type 2 diabetes mellitus	1.97e-06	1.89e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	1.97e-06	1.89e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.97e-06	1.88e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.96e-06	1.88e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	1.96e-06	1.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—BCL2—type 2 diabetes mellitus	1.96e-06	1.88e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.96e-06	1.88e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.96e-06	1.88e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	1.95e-06	1.87e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	1.94e-06	1.86e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	1.94e-06	1.86e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	1.94e-06	1.86e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.93e-06	1.85e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.92e-06	1.84e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	1.92e-06	1.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—RELA—type 2 diabetes mellitus	1.92e-06	1.84e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—INS—type 2 diabetes mellitus	1.9e-06	1.82e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.89e-06	1.81e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.89e-06	1.81e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.89e-06	1.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—C3—type 2 diabetes mellitus	1.89e-06	1.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NOS3—type 2 diabetes mellitus	1.88e-06	1.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PIK3R1—type 2 diabetes mellitus	1.88e-06	1.8e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—type 2 diabetes mellitus	1.88e-06	1.8e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.86e-06	1.78e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.86e-06	1.78e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.86e-06	1.78e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—INS—type 2 diabetes mellitus	1.84e-06	1.77e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	1.84e-06	1.76e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.84e-06	1.76e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	1.83e-06	1.76e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.82e-06	1.75e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	1.82e-06	1.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—AKT1—type 2 diabetes mellitus	1.82e-06	1.74e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.81e-06	1.73e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	1.81e-06	1.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.8e-06	1.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.79e-06	1.72e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AGT—type 2 diabetes mellitus	1.79e-06	1.72e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.78e-06	1.7e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.77e-06	1.7e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.77e-06	1.7e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.76e-06	1.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—LEP—type 2 diabetes mellitus	1.76e-06	1.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOE—type 2 diabetes mellitus	1.76e-06	1.68e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	1.76e-06	1.68e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	1.75e-06	1.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—type 2 diabetes mellitus	1.74e-06	1.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.74e-06	1.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—type 2 diabetes mellitus	1.72e-06	1.65e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—type 2 diabetes mellitus	1.72e-06	1.64e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	1.71e-06	1.64e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	1.71e-06	1.64e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.7e-06	1.63e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	1.69e-06	1.62e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—type 2 diabetes mellitus	1.69e-06	1.62e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.68e-06	1.61e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.68e-06	1.61e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	1.68e-06	1.61e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—INS—type 2 diabetes mellitus	1.68e-06	1.61e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.67e-06	1.6e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	1.67e-06	1.6e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.66e-06	1.6e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	1.66e-06	1.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.66e-06	1.59e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	1.64e-06	1.57e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.64e-06	1.57e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	1.64e-06	1.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NFKB1—type 2 diabetes mellitus	1.62e-06	1.55e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.61e-06	1.55e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.61e-06	1.55e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.61e-06	1.55e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.61e-06	1.55e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.61e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.61e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.61e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.61e-06	1.54e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—AKT1—type 2 diabetes mellitus	1.61e-06	1.54e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	1.59e-06	1.53e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—AKT1—type 2 diabetes mellitus	1.58e-06	1.52e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	1.57e-06	1.51e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.57e-06	1.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—AKT1—type 2 diabetes mellitus	1.54e-06	1.48e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.54e-06	1.48e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	1.54e-06	1.47e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	1.53e-06	1.46e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	1.52e-06	1.46e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	1.51e-06	1.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—SRC—type 2 diabetes mellitus	1.51e-06	1.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—INS—type 2 diabetes mellitus	1.5e-06	1.44e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	1.48e-06	1.42e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.48e-06	1.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.48e-06	1.42e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—SRC—type 2 diabetes mellitus	1.47e-06	1.41e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.47e-06	1.41e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	1.47e-06	1.41e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	1.46e-06	1.4e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	1.46e-06	1.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.45e-06	1.39e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.45e-06	1.39e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	1.43e-06	1.37e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	1.43e-06	1.37e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	1.41e-06	1.35e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	1.4e-06	1.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—SRC—type 2 diabetes mellitus	1.39e-06	1.33e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.39e-06	1.33e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.39e-06	1.33e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	1.39e-06	1.33e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.38e-06	1.33e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.38e-06	1.32e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.36e-06	1.31e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	1.34e-06	1.29e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.34e-06	1.28e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-06	1.28e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.32e-06	1.27e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	1.32e-06	1.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.32e-06	1.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.32e-06	1.26e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.31e-06	1.26e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.31e-06	1.26e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—EGFR—type 2 diabetes mellitus	1.29e-06	1.24e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.29e-06	1.24e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.28e-06	1.23e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.28e-06	1.22e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.28e-06	1.22e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.28e-06	1.22e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.27e-06	1.22e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.26e-06	1.21e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.25e-06	1.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—type 2 diabetes mellitus	1.24e-06	1.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RELA—type 2 diabetes mellitus	1.24e-06	1.19e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.24e-06	1.19e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.23e-06	1.18e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.23e-06	1.18e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	1.22e-06	1.17e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.2e-06	1.15e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.2e-06	1.15e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.19e-06	1.14e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.15e-06	1.1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.15e-06	1.1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.15e-06	1.1e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.14e-06	1.09e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.12e-06	1.08e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.12e-06	1.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.12e-06	1.07e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.11e-06	1.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.11e-06	1.06e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.1e-06	1.05e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.09e-06	1.05e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	1.04e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.08e-06	1.04e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.06e-06	1.02e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.06e-06	1.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.06e-06	1.01e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.05e-06	1.01e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.05e-06	1.01e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.05e-06	1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.05e-06	1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.04e-06	1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.04e-06	9.93e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.04e-06	9.93e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.02e-06	9.81e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—type 2 diabetes mellitus	1.01e-06	9.72e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—type 2 diabetes mellitus	9.93e-07	9.52e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	9.93e-07	9.52e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	9.93e-07	9.52e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SRC—type 2 diabetes mellitus	9.73e-07	9.33e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	9.63e-07	9.23e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.48e-07	9.09e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—type 2 diabetes mellitus	9.36e-07	8.97e-06	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AKT1—type 2 diabetes mellitus	9.35e-07	8.97e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	9.23e-07	8.85e-06	CbGpPWpGaD
Docetaxel—ABCC1—Disease—AKT1—type 2 diabetes mellitus	9.16e-07	8.78e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—INS—type 2 diabetes mellitus	9.06e-07	8.68e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.7e-07	8.34e-06	CbGpPWpGaD
Docetaxel—EGFR—Disease—AKT1—type 2 diabetes mellitus	8.64e-07	8.28e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	8.56e-07	8.2e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.56e-07	8.2e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	8.52e-07	8.17e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	8.41e-07	8.06e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	8.3e-07	7.96e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	8.16e-07	7.82e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	7.94e-07	7.61e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	7.94e-07	7.61e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	7.94e-07	7.61e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	7.79e-07	7.47e-06	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	7.67e-07	7.36e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	7.63e-07	7.31e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	7.6e-07	7.29e-06	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—AKT1—type 2 diabetes mellitus	7.42e-07	7.12e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	7.4e-07	7.1e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	7.31e-07	7.01e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	7.26e-07	6.96e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	7.02e-07	6.73e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	6.88e-07	6.6e-06	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	6.75e-07	6.47e-06	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	6.69e-07	6.42e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	6.67e-07	6.39e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—type 2 diabetes mellitus	6.56e-07	6.28e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	6.55e-07	6.28e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	6.53e-07	6.26e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	6.46e-07	6.19e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.05e-07	5.8e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	5.69e-07	5.45e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	5.58e-07	5.35e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	5.12e-07	4.9e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	4.89e-07	4.69e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	4.89e-07	4.69e-06	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	4.84e-07	4.64e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.48e-07	4.29e-06	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.65e-07	3.5e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.25e-07	2.16e-06	CbGpPWpGaD
